Ordering for healthcare
Nightingale currently provides analysis services for public health research and has recently started a pilot study of its clinical service. We received CE marking of our blood biomarker analysis platform in 2017. The CE mark enables the clinical use of the analysis service and the analysed measures of creatinine, glucose, total cholesterol, HDL-C, LDL-C, triglycerides, Apo A1 and Apo B in the EU region.
For inquiries regarding clinical solutions, please leave us a message in the box below.